your market intelligence analyst
Search Results
125 results
Your search is now limited to «Monoclonal Antibody Therapy» expert search. 07/18/2019 07:36
On the basis of drug type the cancer immunotherapy drug discovery outsourcing market is segmented into monoclonal antibodies, immunomodulators, oncolytic viral therapies and cancer vaccines, and others.
More from
GlobeNewswire 07/17/2019 16:01
To achieve this, the DART molecule combines a portion of an antibody recognizing CD3, an activating molecule expressed by T cells, with an arm that recognizes CD123 on the target cancer cells.
More from GlobeNewswire:
Healio News 07/17/2019 12:50
The 313 patients enrolled onto nongenomically matched trials received treatments such as immunotherapy, monoclonal antibodies and antibody-drug conjugates, Subbiah said.
More from Healio News: 07/16/2019 06:54
Conditions : Advanced Malignant Solid Neoplasm; Metastatic Carcinoma in the Liver; Metastatic Carcinoma in the Lung; Metastatic Malignant Neoplasm in the Thoracic Cavity; Metastatic Malignant Solid Neoplasm Interventions : Drug: Anti-GITR Agonistic Monoclonal Antibody BMS-986156; Biological: Ipilimumab; Biological: Nivolumab; Radiation: Stereotactic Body Radiation Therapy Sponsors : M.D. Anderson Cancer Center; National Cancer Institute (NCI) Not yet recruiting.
More from
Orphan designation: Recombinant chimeric monoclonal antibody against CD20, Treatment of chronic lymphocytic leukaemia, 26/11/2009, Positive.
More from European Medicines Agency - EMEA (EU):
Imfinzi, as part of a larger development programme, is also being assessed as a monotherapy and in combination with anti-CTLA4 monoclonal antibody tremelimumab as a treatment for patients with NSCLC, SCLC, bladder cancer, head and neck cancer, biliary tract cancer, liver cancer, cervical cancer, and other solid tumours.
More from Pharmaceutical Business Review:
PR Newswire 07/13/2019 06:05
BEIJING, June 13, 2019 /PRNewswire/ -- I-Mab Biopharma ("I-Mab"), a clinical stage biotech company exclusively focusing on discovery and development of innovative biologics in immuno-oncology and autoimmune diseases, announces that the National Medical Products Administration (NMPA) has...
More from PR Newswire:
(MENAFN - PR Newswire) BEIJING, June 13, 2019 /PRNewswire/ -- I-Mab Biopharma ("I-Mab"), a clinical stage biotech company exclusively focusing on discovery and development of innov...
More from Middle East North Africa Financial Network (MENAFN):
Benzinga 07/11/2019 10:23
The investigational asset has been granted Breakthrough Therapy Designation.
More from Benzinga:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications